NYSE:DVAHealthcare
DaVita (DVA) Stock Looks Discounted On Earnings While Returns Look Strong
DaVita stock has delivered a 78.0% return over the past three years, yet the latest valuation checks still suggest the shares lean cheap rather than fully priced in.
Over three years DaVita has returned 78.0%, which puts more focus on whether the current valuation leaves enough room for further upside.
Future cash generation from its dialysis network can support the current share price, but ongoing cost pressures and reimbursement uncertainty may limit how much investors are willing to pay...